Global Molecular Cancer Therapeutics Market Growth (Status and Outlook) 2022-2028
Molecular cancer therapeutics focuses on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology.
The global market for Molecular Cancer Therapeutics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Molecular Cancer Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Molecular Cancer Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Molecular Cancer Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Molecular Cancer Therapeutics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Molecular Cancer Therapeutics players cover Phoenix Molecular Designs, Prelude Therapeutics, Tempus, Bracco and iOmx Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Molecular Cancer Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Molecular Cancer Therapeutics market, with both quantitative and qualitative data, to help readers understand how the Molecular Cancer Therapeutics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Molecular Cancer Therapeutics market and forecasts the market size by Type (Monoclonal Antibodies and Small Molecule Inhibitors,), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer and Leukemia), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibodies
Small Molecule Inhibitors
Segmentation by application
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Phoenix Molecular Designs
Prelude Therapeutics
Tempus
Bracco
iOmx Therapeutics
OncoDNA
Sapience Therapeutics
Caris Life Sciences
Hera Biolabs
CV6 Therapeutics
Carrick Therapeutics
Foundation Medicine
Cybrexa Therapeutics
Chapter Introduction
Chapter 1: Scope of Molecular Cancer Therapeutics, Research Methodology, etc.
Chapter 2: Executive Summary, global Molecular Cancer Therapeutics market size and CAGR, Molecular Cancer Therapeutics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Molecular Cancer Therapeutics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Molecular Cancer Therapeutics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Molecular Cancer Therapeutics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Phoenix Molecular Designs, Prelude Therapeutics, Tempus, Bracco, iOmx Therapeutics, OncoDNA, Sapience Therapeutics, Caris Life Sciences and Hera Biolabs, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Cancer Therapeutics Market Size 2017-2028
2.1.2 Molecular Cancer Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Molecular Cancer Therapeutics Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Small Molecule Inhibitors
2.3 Molecular Cancer Therapeutics Market Size by Type
2.3.1 Molecular Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Molecular Cancer Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Molecular Cancer Therapeutics Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Colorectal Cancer
2.4.4 Leukemia
2.4.5 Others
2.5 Molecular Cancer Therapeutics Market Size by Application
2.5.1 Molecular Cancer Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Molecular Cancer Therapeutics Market Size Market Share by Application (2017-2022)
3 Molecular Cancer Therapeutics Market Size by Player
3.1 Molecular Cancer Therapeutics Market Size Market Share by Players
3.1.1 Global Molecular Cancer Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Molecular Cancer Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Molecular Cancer Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Molecular Cancer Therapeutics by Regions
4.1 Molecular Cancer Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Molecular Cancer Therapeutics Market Size Growth (2017-2022)
4.3 APAC Molecular Cancer Therapeutics Market Size Growth (2017-2022)
4.4 Europe Molecular Cancer Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Molecular Cancer Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Molecular Cancer Therapeutics Market Size by Country (2017-2022)
5.2 Americas Molecular Cancer Therapeutics Market Size by Type (2017-2022)
5.3 Americas Molecular Cancer Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Cancer Therapeutics Market Size by Region (2017-2022)
6.2 APAC Molecular Cancer Therapeutics Market Size by Type (2017-2022)
6.3 APAC Molecular Cancer Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Molecular Cancer Therapeutics by Country (2017-2022)
7.2 Europe Molecular Cancer Therapeutics Market Size by Type (2017-2022)
7.3 Europe Molecular Cancer Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Cancer Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Molecular Cancer Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Molecular Cancer Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Molecular Cancer Therapeutics Market Forecast
10.1 Global Molecular Cancer Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Molecular Cancer Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Molecular Cancer Therapeutics Forecast
10.1.3 APAC Molecular Cancer Therapeutics Forecast
10.1.4 Europe Molecular Cancer Therapeutics Forecast
10.1.5 Middle East & Africa Molecular Cancer Therapeutics Forecast
10.2 Americas Molecular Cancer Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Molecular Cancer Therapeutics Market Forecast
10.2.2 Canada Molecular Cancer Therapeutics Market Forecast
10.2.3 Mexico Molecular Cancer Therapeutics Market Forecast
10.2.4 Brazil Molecular Cancer Therapeutics Market Forecast
10.3 APAC Molecular Cancer Therapeutics Forecast by Region (2023-2028)
10.3.1 China Molecular Cancer Therapeutics Market Forecast
10.3.2 Japan Molecular Cancer Therapeutics Market Forecast
10.3.3 Korea Molecular Cancer Therapeutics Market Forecast
10.3.4 Southeast Asia Molecular Cancer Therapeutics Market Forecast
10.3.5 India Molecular Cancer Therapeutics Market Forecast
10.3.6 Australia Molecular Cancer Therapeutics Market Forecast
10.4 Europe Molecular Cancer Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Molecular Cancer Therapeutics Market Forecast
10.4.2 France Molecular Cancer Therapeutics Market Forecast
10.4.3 UK Molecular Cancer Therapeutics Market Forecast
10.4.4 Italy Molecular Cancer Therapeutics Market Forecast
10.4.5 Russia Molecular Cancer Therapeutics Market Forecast
10.5 Middle East & Africa Molecular Cancer Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Molecular Cancer Therapeutics Market Forecast
10.5.2 South Africa Molecular Cancer Therapeutics Market Forecast
10.5.3 Israel Molecular Cancer Therapeutics Market Forecast
10.5.4 Turkey Molecular Cancer Therapeutics Market Forecast
10.5.5 GCC Countries Molecular Cancer Therapeutics Market Forecast
10.6 Global Molecular Cancer Therapeutics Forecast by Type (2023-2028)
10.7 Global Molecular Cancer Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Phoenix Molecular Designs
11.1.1 Phoenix Molecular Designs Company Information
11.1.2 Phoenix Molecular Designs Molecular Cancer Therapeutics Product Offered
11.1.3 Phoenix Molecular Designs Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Phoenix Molecular Designs Main Business Overview
11.1.5 Phoenix Molecular Designs Latest Developments
11.2 Prelude Therapeutics
11.2.1 Prelude Therapeutics Company Information
11.2.2 Prelude Therapeutics Molecular Cancer Therapeutics Product Offered
11.2.3 Prelude Therapeutics Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Prelude Therapeutics Main Business Overview
11.2.5 Prelude Therapeutics Latest Developments
11.3 Tempus
11.3.1 Tempus Company Information
11.3.2 Tempus Molecular Cancer Therapeutics Product Offered
11.3.3 Tempus Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Tempus Main Business Overview
11.3.5 Tempus Latest Developments
11.4 Bracco
11.4.1 Bracco Company Information
11.4.2 Bracco Molecular Cancer Therapeutics Product Offered
11.4.3 Bracco Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bracco Main Business Overview
11.4.5 Bracco Latest Developments
11.5 iOmx Therapeutics
11.5.1 iOmx Therapeutics Company Information
11.5.2 iOmx Therapeutics Molecular Cancer Therapeutics Product Offered
11.5.3 iOmx Therapeutics Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 iOmx Therapeutics Main Business Overview
11.5.5 iOmx Therapeutics Latest Developments
11.6 OncoDNA
11.6.1 OncoDNA Company Information
11.6.2 OncoDNA Molecular Cancer Therapeutics Product Offered
11.6.3 OncoDNA Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 OncoDNA Main Business Overview
11.6.5 OncoDNA Latest Developments
11.7 Sapience Therapeutics
11.7.1 Sapience Therapeutics Company Information
11.7.2 Sapience Therapeutics Molecular Cancer Therapeutics Product Offered
11.7.3 Sapience Therapeutics Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sapience Therapeutics Main Business Overview
11.7.5 Sapience Therapeutics Latest Developments
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Information
11.8.2 Caris Life Sciences Molecular Cancer Therapeutics Product Offered
11.8.3 Caris Life Sciences Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Caris Life Sciences Main Business Overview
11.8.5 Caris Life Sciences Latest Developments
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Information
11.9.2 Hera Biolabs Molecular Cancer Therapeutics Product Offered
11.9.3 Hera Biolabs Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hera Biolabs Main Business Overview
11.9.5 Hera Biolabs Latest Developments
11.10 CV6 Therapeutics
11.10.1 CV6 Therapeutics Company Information
11.10.2 CV6 Therapeutics Molecular Cancer Therapeutics Product Offered
11.10.3 CV6 Therapeutics Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 CV6 Therapeutics Main Business Overview
11.10.5 CV6 Therapeutics Latest Developments
11.11 Carrick Therapeutics
11.11.1 Carrick Therapeutics Company Information
11.11.2 Carrick Therapeutics Molecular Cancer Therapeutics Product Offered
11.11.3 Carrick Therapeutics Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Carrick Therapeutics Main Business Overview
11.11.5 Carrick Therapeutics Latest Developments
11.12 Foundation Medicine
11.12.1 Foundation Medicine Company Information
11.12.2 Foundation Medicine Molecular Cancer Therapeutics Product Offered
11.12.3 Foundation Medicine Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Foundation Medicine Main Business Overview
11.12.5 Foundation Medicine Latest Developments
11.13 Cybrexa Therapeutics
11.13.1 Cybrexa Therapeutics Company Information
11.13.2 Cybrexa Therapeutics Molecular Cancer Therapeutics Product Offered
11.13.3 Cybrexa Therapeutics Molecular Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Cybrexa Therapeutics Main Business Overview
11.13.5 Cybrexa Therapeutics Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Molecular Cancer Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Small Molecule Inhibitors
Table 4. Molecular Cancer Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Molecular Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Molecular Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Molecular Cancer Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Molecular Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Molecular Cancer Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Molecular Cancer Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Molecular Cancer Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Molecular Cancer Therapeutics Key Players Head office and Products Offered
Table 13. Molecular Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Molecular Cancer Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Molecular Cancer Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Molecular Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Molecular Cancer Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Molecular Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Molecular Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Molecular Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Molecular Cancer Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Molecular Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Molecular Cancer Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Molecular Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Molecular Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Molecular Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Molecular Cancer Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Molecular Cancer Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Molecular Cancer Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Molecular Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Molecular Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Molecular Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Molecular Cancer Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Molecular Cancer Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Molecular Cancer Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Molecular Cancer Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Molecular Cancer Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Molecular Cancer Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Molecular Cancer Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Molecular Cancer Therapeutics
Table 43. Key Market Challenges & Risks of Molecular Cancer Therapeutics
Table 44. Key Industry Trends of Molecular Cancer Therapeutics
Table 45. Global Molecular Cancer Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Molecular Cancer Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Molecular Cancer Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Molecular Cancer Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Molecular Cancer Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Molecular Cancer Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Phoenix Molecular Designs Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 52. Phoenix Molecular Designs Molecular Cancer Therapeutics Product Offered
Table 53. Phoenix Molecular Designs Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Phoenix Molecular Designs Main Business
Table 55. Phoenix Molecular Designs Latest Developments
Table 56. Prelude Therapeutics Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 57. Prelude Therapeutics Molecular Cancer Therapeutics Product Offered
Table 58. Prelude Therapeutics Main Business
Table 59. Prelude Therapeutics Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Prelude Therapeutics Latest Developments
Table 61. Tempus Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 62. Tempus Molecular Cancer Therapeutics Product Offered
Table 63. Tempus Main Business
Table 64. Tempus Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Tempus Latest Developments
Table 66. Bracco Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 67. Bracco Molecular Cancer Therapeutics Product Offered
Table 68. Bracco Main Business
Table 69. Bracco Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Bracco Latest Developments
Table 71. iOmx Therapeutics Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 72. iOmx Therapeutics Molecular Cancer Therapeutics Product Offered
Table 73. iOmx Therapeutics Main Business
Table 74. iOmx Therapeutics Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. iOmx Therapeutics Latest Developments
Table 76. OncoDNA Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 77. OncoDNA Molecular Cancer Therapeutics Product Offered
Table 78. OncoDNA Main Business
Table 79. OncoDNA Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. OncoDNA Latest Developments
Table 81. Sapience Therapeutics Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 82. Sapience Therapeutics Molecular Cancer Therapeutics Product Offered
Table 83. Sapience Therapeutics Main Business
Table 84. Sapience Therapeutics Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Sapience Therapeutics Latest Developments
Table 86. Caris Life Sciences Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 87. Caris Life Sciences Molecular Cancer Therapeutics Product Offered
Table 88. Caris Life Sciences Main Business
Table 89. Caris Life Sciences Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Caris Life Sciences Latest Developments
Table 91. Hera Biolabs Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 92. Hera Biolabs Molecular Cancer Therapeutics Product Offered
Table 93. Hera Biolabs Main Business
Table 94. Hera Biolabs Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Hera Biolabs Latest Developments
Table 96. CV6 Therapeutics Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 97. CV6 Therapeutics Molecular Cancer Therapeutics Product Offered
Table 98. CV6 Therapeutics Main Business
Table 99. CV6 Therapeutics Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. CV6 Therapeutics Latest Developments
Table 101. Carrick Therapeutics Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 102. Carrick Therapeutics Molecular Cancer Therapeutics Product Offered
Table 103. Carrick Therapeutics Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Carrick Therapeutics Main Business
Table 105. Carrick Therapeutics Latest Developments
Table 106. Foundation Medicine Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 107. Foundation Medicine Molecular Cancer Therapeutics Product Offered
Table 108. Foundation Medicine Main Business
Table 109. Foundation Medicine Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Foundation Medicine Latest Developments
Table 111. Cybrexa Therapeutics Details, Company Type, Molecular Cancer Therapeutics Area Served and Its Competitors
Table 112. Cybrexa Therapeutics Molecular Cancer Therapeutics Product Offered
Table 113. Cybrexa Therapeutics Main Business
Table 114. Cybrexa Therapeutics Molecular Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cybrexa Therapeutics Latest Developments
List of Figures
List of Figures
Figure 1. Molecular Cancer Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Cancer Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Molecular Cancer Therapeutics Market Size Market Share by Type in 2021
Figure 7. Molecular Cancer Therapeutics in Lung Cancer
Figure 8. Global Molecular Cancer Therapeutics Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 9. Molecular Cancer Therapeutics in Breast Cancer
Figure 10. Global Molecular Cancer Therapeutics Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 11. Molecular Cancer Therapeutics in Colorectal Cancer
Figure 12. Global Molecular Cancer Therapeutics Market: Colorectal Cancer (2017-2022) & ($ Millions)
Figure 13. Molecular Cancer Therapeutics in Leukemia
Figure 14. Global Molecular Cancer Therapeutics Market: Leukemia (2017-2022) & ($ Millions)
Figure 15. Molecular Cancer Therapeutics in Others
Figure 16. Global Molecular Cancer Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Molecular Cancer Therapeutics Market Size Market Share by Application in 2021
Figure 18. Global Molecular Cancer Therapeutics Revenue Market Share by Player in 2021
Figure 19. Global Molecular Cancer Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Molecular Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Molecular Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Molecular Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Molecular Cancer Therapeutics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Molecular Cancer Therapeutics Value Market Share by Country in 2021
Figure 25. Americas Molecular Cancer Therapeutics Consumption Market Share by Type in 2021
Figure 26. Americas Molecular Cancer Therapeutics Market Size Market Share by Application in 2021
Figure 27. United States Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Molecular Cancer Therapeutics Market Size Market Share by Region in 2021
Figure 32. APAC Molecular Cancer Therapeutics Market Size Market Share by Application in 2021
Figure 33. China Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Molecular Cancer Therapeutics Market Size Market Share by Country in 2021
Figure 40. Europe Molecular Cancer Therapeutics Market Size Market Share by Type in 2021
Figure 41. Europe Molecular Cancer Therapeutics Market Size Market Share by Application in 2021
Figure 42. Germany Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Molecular Cancer Therapeutics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Molecular Cancer Therapeutics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Molecular Cancer Therapeutics Market Size Market Share by Application in 2021
Figure 50. Egypt Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Molecular Cancer Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. United States Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. China Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. India Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. France Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. UK Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Molecular Cancer Therapeutics Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets